What’s New for the 2017-2018 Flu Season: Recommendations for Children
= Date: Tuesday, November 7, 2017
Time: 2:00-3:00 pm (Eastern Time)
The recordings (audio, slides, and transcript) for this call will be posted on the webpage a few days after the COCA Call.
Follow these steps to earn free continuing education.
Overview
Influenza remains a serious threat to child morbidity and mortality. More than 100 flu-associated deaths in children during the 2016–2017 influenza season were reported to the Centers for Disease Control and Prevention (CDC). Clinicians play a critical role in taking action to immunize children, children’s family members, caregivers, and themselves. The early use of antiviral drugs in children can reduce the duration of symptoms, and prevent serious complications of influenza. However, immunization remains the most effective way to prevent influenza illness and its complications.
During this COCA call, subject matter experts from the American Academy of Pediatrics (AAP) and CDC will highlight critical information about this year’s flu season, and discuss strategies primary care providers and medical subspecialists can use to improve flu prevention and control in children.
At the conclusion of the session, the participant will be able to accomplish the following:
- Describe what strains of flu virus are predicted to circulate in the 2017–2018 season.
- Identify key recommendations in the AAP influenza policy statement, “Recommendations for Prevention and Control of Influenza in Children, 2017–2018”.
- List recommendations regarding antiviral use in children.
- Discuss vaccine effectiveness and clarify recommendations for the 2017–2018 season, including those related to the live attenuated influenza vaccine.
-
- Slides: View Nowpdf icon
Angela Campbell, MD, MPH, FAAP
Medical Officer
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Flor Munoz, MD, FAAP
Associate Professor
Pediatric Infectious Diseases
Baylor College of Medicine
Member, AAP Committee on Infectious Diseases
- Audio conference call on Thursday, 11/07/17: 2:00 – 3:00 PM (Eastern Time)
- Web-on-demand training after 3:00 PM on 11/07/17
- Materials: PowerPoint slide set
- CDC Influenza (Flu)
- CDC FluView
- CDC Storage and Handling Toolkit
- AAP Policy Statement – Recommendations for Prevention and Control of Influenza in Children, (2017–2018)external icon
- AAP Red Book Online Influenza Resource Pageexternal icon
- AAP Vaccine Storage and Handlingexternal icon
- AAP Immunization Training Guide & Practice Procedure Manualpdf iconexternal icon
- AAP What’s the Latest with the Fluexternal icon
Accreditation Statements
CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides 1.0 contact hour.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This program is a designated event for pharmacists to receive) 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-17-242-L04-P and enduring 0387-0000-17-242-H04-P course category.
This activity has been designated as Knowledge-Based.
Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
For Certified Public Health Professionals (CPH)
The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.
CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.orgexternal icon.
AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.
DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept commercial support for this activity.